GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
10.6074 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9 |
9.56988 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
8.70152 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, FABP3, FABP4, HSD17B1, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2 |
8.10441 |
[BP] GO:0007215 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
7.20457 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, CA12, CA2, CA7, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, ESR1, FABP3, FABP4, GRIA2, GRIA4, GRIK5, GRM1, GRM5, HCAR2, HSD17B1, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, SLC1A1, XDH |
7.18864 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PIK3CA, PPARA, PPARG, PTGS1, PTGS2, XDH |
7.1782 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.94437 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG, SLC1A1 |
6.94437 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
6.78641 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.54948 |
[BP] GO:0007188 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
6.36875 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.13125 |
[BP] GO:0007187 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8 |
5.79044 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, FABP3, PPARA, PPARG, SLC1A1 |
5.72853 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.68075 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, FABP4, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2 |
5.48408 |
[BP] GO:0007196 |
None
|
GRM1, GRM3, GRM5, GRM8 |
5.35422 |
[BP] GO:0007268 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.35422 |
[BP] GO:0098916 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.35422 |
[BP] GO:0006631 |
fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG, PTGS1, PTGS2 |
5.32198 |
[BP] GO:0099536 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.3077 |
[BP] GO:0099537 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
5.3077 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.3077 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.3077 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.3077 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.23763 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, GRM1, GRM3, GRM5, GRM8, PTGS2 |
5.15634 |
[BP] GO:0006690 |
icosanoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.13774 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, ESR1, HSD17B1 |
4.93745 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, HSP90AB1, NQO2, PTGS1 |
4.88734 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, GRIK5, GRM5, HSP90AB1, MMP2, MMP9, PIK3CA, PPARA, PPARG, PTGS2 |
4.77089 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CHRM5, FABP3, GRIA2, GRIA4, GRIK5, PPARA, PPARG, SLC1A1 |
4.68002 |
[BP] GO:0007216 |
None
|
GRM1, GRM3, GRM5, GRM8 |
4.65818 |
[BP] GO:0007154 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, PPARG, PTGS2, SLC1A1 |
4.53327 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.44692 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, NQO2, PPARG, PTGS1, PTGS2, XDH |
4.39167 |
[BP] GO:0007267 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
4.37723 |
[BP] GO:0007200 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, ESR1, GRM5 |
4.28574 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
4.11179 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, CA2, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, GRM1, GRM3, GRM5, GRM8, HCAR2, PIK3CA, PIK3CB, PPARG |
4.0714 |
[BP] GO:0023052 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, ESR2, GRIA2, GRIK5, GRM1, GRM3, GRM5, SLC1A1 |
3.92826 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.8701 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.8701 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.80126 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, CA12, CA2, CA7, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PPARG |
3.79512 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.7128 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.7128 |
[BP] GO:0032787 |
None
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA, PPARG, PTGS1, PTGS2 |
3.7128 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HSD17B1 |
3.67852 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.63151 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, GRIK5, GRM5, HSP90AA1, HSP90AB1, MMP2, PIK3CA, PPARA, PPARG, PTGS2 |
3.63151 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, PTGS2 |
3.58986 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, FABP3, FABP4, GRIK5, GRM1, GRM5, HCAR2, HSP90AA1, HSP90AB1, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, SLC1A1, XDH |
3.52344 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, CA12, CA2, CA7, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, PIK3CA, PIK3CB, PPARG |
3.45478 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, CA1, CA2, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, ESR1, ESR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, HSP90AB1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTPN1 |
3.38925 |
[BP] GO:0060078 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5, GRM5 |
3.26512 |
[BP] GO:2001225 |
regulation of chloride transport
|
CA2, CA7, GRM5 |
3.26512 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.26512 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, CSNK2A1, CYP19A1, CYP1A1, HSD17B1, PIK3CA, PIK3CB, PTGS1, PTGS2 |
3.23815 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, CDC25B, CHRM5, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HSP90AB1, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, XDH |
3.19999 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, CDC25B, CHRM5, FABP3, FABP4, GRM1, GRM3, GRM5, GRM8, HSP90AB1, MMP9, PIK3CA, PIK3CB, PPARA, PTGS2, PTPN1, XDH |
3.15675 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AB1, MMP9, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, XDH |
3.0933 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, ESR1, ESR2, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AB1, MMP9, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, XDH |
3.00708 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, ESR1, ESR2, FABP3, GRIK5, GRM1, GRM5, HCAR2, HSP90AA1, HSP90AB1, MMP1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, XDH |
2.98089 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, GRIK5, GRM5, HSP90AA1, HSP90AB1, MMP2, MMP9, PIK3CA, PPARA, PPARG, PTGS2 |
2.945 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, FABP3, FABP4, HSP90AA1, MMP1, MMP2, MMP9, PIK3CB, XDH |
2.92454 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, ESR1, GRIK5, HCAR2, HSP90AB1, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS2, PTPN1, XDH |
2.89743 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, GRIK5, HSP90AA1, HSP90AB1, PTGS2, SLC1A1 |
2.88808 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GRM1, HCAR2, HSP90AB1, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.88148 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, FABP3, HCAR2, PPARA, PPARG, PTGS2 |
2.87462 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, GRM1, HCAR2, HSP90AB1, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.86552 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.75233 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, ESR1, HCAR2, HSD17B1 |
2.73136 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, ESR1, GRIK5, HCAR2, HSP90AB1, MMP9, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, XDH |
2.7267 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, CSNK2A1, CYP1B1, ESR1, GRIK5, HCAR2, HSP90AB1, MMP9, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, XDH |
2.68199 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, GRM1, HCAR2, PTGS2, SLC1A1 |
2.67773 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, PPARA, PPARG, PTGS2 |
2.67713 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, CA1, CSNK2A1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, MMP2, MMP9, PIK3CA, PIK3CB, PTPN1 |
2.65662 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, CA2, CA9, CSNK2A1, CYP1A2, ESR1, FABP3, GRM5, MMP2, PPARA, PPARG, PTGS2 |
2.64475 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, PTGS2, SLC1A1 |
2.64475 |
[BP] GO:0099566 |
None
|
GRM1, GRM5 |
2.46221 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46221 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSD17B1, HSP90AA1, HSP90AB1, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, PTPN1, SLC1A1, XDH |
2.42223 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, CDC25B, CHRM1, CSNK2A1, CYP1B1, ESR1, FABP3, MMP2, MMP9, PPARG, PTGS1, PTGS2, XDH |
2.37579 |
[BP] GO:0014070 |
response to organic cyclic compound
|
CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, HSP90AB1, PPARG, PTGS2 |
2.37579 |
[BP] GO:0048660 |
regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PPARG, PTGS2 |
2.37579 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, CDC25B, CSNK2A1, ESR1, FABP4, GRM1, GRM3, GRM5, HSP90AA1, HSP90AB1, MMP9, PIK3CA, PIK3CB, PPARG, PTGS2, PTPN1, XDH |
2.3529 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, CA2, CA7, CHRM1, CYP19A1, GRIK5, GRM5, HCAR2, HSP90AB1, MMP9, PIK3CB, PPARA, PPARG, PTGS2, PTPN1 |
2.3466 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, FABP3, GRIA2, GRIA4, GRIK5, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, SLC1A1, XDH |
2.31479 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.30073 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, CYP1B1, ESR1, GRIK5, GRM5, MMP2, MMP9, PIK3CA, PPARG, PTGS2 |
2.25756 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, CA2, CYP1A1, CYP1A2, CYP1B1, FABP4, MMP9, PTGS2 |
2.25756 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1 |
2.25756 |
[BP] GO:0035902 |
response to immobilization stress
|
CYP1A1, CYP1A2, PPARG |
2.25756 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.25756 |
[BP] GO:0060079 |
None
|
ADORA1, GRIA2, GRIA4, GRIK5 |
2.24841 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, CDC25B, FABP3, GRM1, GRM5, HSP90AB1, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.24385 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, CDC25B, FABP3, GRM1, GRM5, HSP90AB1, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.24385 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP4, GRIK5, GRM5, HSP90AB1, MMP2, MMP9, PIK3CA, PPARG, PTGS2 |
2.24385 |
[BP] GO:1905323 |
None
|
HSP90AA1, HSP90AB1 |
2.2259 |
[BP] GO:0033031 |
positive regulation of neutrophil apoptotic process
|
HCAR2, PIK3CB |
2.2259 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
CA2, CA7 |
2.2259 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2259 |
[BP] GO:0035235 |
None
|
GRIA2, GRIA4, GRIK5 |
2.17975 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, CDC25B, GRM1, GRM5, HSP90AB1, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.17587 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, CA2, CA7, CHRM1, CSNK2A1, CYP19A1, CYP1B1, GRIK5, GRM5, HCAR2, HSP90AB1, MMP9, PIK3CB, PPARA, PPARG, PTGS2, PTPN1 |
2.16721 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, CA2, CA6, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, ESR1, FABP3, FABP4, GRIK5, GRM1, GRM5, HSP90AA1, HSP90AB1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, PTPN1 |
2.16679 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, ESR1, FABP4, HSP90AB1, MMP2, PPARA, PPARG, PTGS2, PTPN1 |
2.14651 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, FABP4, MMP9, PTGS2 |
2.14651 |
[BP] GO:0008217 |
None
|
ADORA1, PPARA, PPARG, PTGS1, PTGS2 |
2.13507 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, MMP2, MMP9, PTGS2 |
2.13227 |
[BP] GO:0046320 |
None
|
FABP3, PPARA, PPARG |
2.10768 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.04434 |
[BP] GO:0032800 |
receptor biosynthetic process
|
ACHE, PPARG |
2.04434 |
[BP] GO:0010891 |
None
|
PPARA, PPARG |
2.04434 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, CDC25B, GRM1, GRM5, HSP90AB1, MMP9, PIK3CA, PIK3CB, PTGS2, PTPN1, XDH |
2.03912 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, HSP90AA1, HSP90AB1, MMP2, MMP9, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, PTPN1 |
2.03717 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CHRM1, CHRM3, CHRM5, FABP3, GRIA2, GRIA4, GRIK5, HSP90AA1, HSP90AB1, MMP9, PPARA, PPARG, SLC1A1, XDH |
2.03717 |
[BP] GO:0071702 |
None
|
ADORA1, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CHRM5, FABP3, HSP90AA1, PPARA, PPARG, SLC1A1 |
2.03717 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, GRM5 |
2.0291 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, GRM1, GRM5, HSP90AB1, PIK3CA, PIK3CB, PTPN1 |
2.01661 |
[BP] GO:0006937 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, PTGS2 |
2.01098 |
[BP] GO:0045923 |
None
|
PPARA, PPARG, PTGS2 |
2.00527 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, CA2, CYP1A1, GRM1, HSP90AA1, HSP90AB1, MMP2, PPARA, PPARG, PTGS2 |
2.00527 |
[BP] GO:0022900 |
electron transport chain
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.00502 |
[BP] GO:0019217 |
None
|
FABP3, PPARA, PPARG, PTGS2 |
2.00405 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA9, CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, PTGS2, SLC1A1 |
6.96872 |
[CC] GO:0097060 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
6.46097 |
[CC] GO:0044456 |
None
|
ACHE, ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
4.72843 |
[CC] GO:0045211 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM3 |
4.37723 |
[CC] GO:0042734 |
None
|
GRIK5, GRM1, GRM3, GRM5, GRM8 |
3.67787 |
[CC] GO:0043005 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PTGS2 |
3.44972 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, CA9, CHRM1, CHRM2, CHRM3, GRIA2, GRIA4, GRIK5, GRM3, HSP90AA1, HSP90AB1, PTGS1 |
2.98911 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, CA9, CHRM1, CHRM2, CHRM3, GRIA2, GRIA4, GRIK5, GRM3, HSP90AA1, HSP90AB1, PTGS1 |
2.98911 |
[CC] GO:0120025 |
None
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2 |
2.73315 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, CA12, CA14, CA2, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, ESR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, MMP2, PIK3CA, PIK3CB, PTPN1, SLC1A1 |
2.68747 |
[CC] GO:0014069 |
None
|
ADORA1, CHRM1, GRIK5, GRM1, GRM3, GRM5 |
2.52652 |
[CC] GO:0099572 |
None
|
ADORA1, CHRM1, GRIK5, GRM1, GRM3, GRM5 |
2.52652 |
[CC] GO:0042995 |
cell projection
|
ADORA1, AKR1B1, CA2, CHRM1, CHRM2, CHRM3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, PIK3CA, PTGS2 |
2.51664 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, CA12, CA14, CA2, CA9, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, HSP90AA1, HSP90AB1, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, SLC1A1 |
2.47338 |
[CC] GO:0097458 |
None
|
ADORA1, CA2, CHRM1, CHRM2, CHRM3, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, PTGS1, PTGS2 |
2.47049 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, CA2, CA9, CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HSP90AA1, HSP90AB1, PTGS2, SLC1A1 |
2.10768 |
[CC] GO:0045202 |
None
|
ACHE, CHRM1, CHRM2, CHRM3, CHRM5, GRIA2 |
2.01661 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
15.255 |
[MF] GO:0046914 |
transition metal ion binding
|
CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, PPARG, PTPN1, XDH |
11.7664 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
9.78967 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
8.70152 |
[MF] GO:0008066 |
None
|
GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8 |
8.68552 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM5 |
7.41054 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, PPARG, PTPN1 |
7.18864 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
6.96828 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.54948 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9 |
5.78661 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.72853 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.49921 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
5.49312 |
[MF] GO:0043167 |
ion binding
|
ACHE, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, FABP3, FABP4, HSD17B1, HSP90AA1, HSP90AB1, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PPARA, PPARG, PTGS1, PTGS2, PTPN1, SLC1A1, XDH |
5.33557 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, PTGS1, PTGS2 |
5.25762 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, PPARA, PPARG |
5.11467 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, HSP90AA1, MMP1, MMP2, MMP9, NQO2, PIK3CA, PIK3CB, PTGS1, PTGS2, PTPN1, XDH |
4.63758 |
[MF] GO:0043169 |
cation binding
|
ACHE, CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, PPARG, PTGS1, PTGS2, PTPN1, SLC1A1, XDH |
4.57516 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
4.53327 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, HSD17B1, NQO2, PTGS1, PTGS2, XDH |
4.53327 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, PPARA, PPARG |
4.41069 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13 |
4.27488 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.27176 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, PPARA, PPARG |
4.25106 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
4.09002 |
[MF] GO:0005506 |
iron ion binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, XDH |
4.03677 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, ESR1, ESR2, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, PPARA, PPARG |
3.8701 |
[MF] GO:0030235 |
nitric-oxide synthase regulator activity
|
ESR1, HSP90AA1, HSP90AB1 |
3.7128 |
[MF] GO:0046872 |
metal ion binding
|
CA1, CA12, CA14, CA2, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, ESR1, ESR2, MMP1, MMP2, MMP9, NQO2, PPARA, PPARG, PTGS1, PTGS2, PTPN1, SLC1A1, XDH |
3.69718 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, PPARG |
3.56492 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, GRIA2, GRIA4, GRIK5, GRM1, GRM3, GRM5, GRM8, HCAR2, PPARG |
3.56492 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.46994 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6 |
3.26512 |
[MF] GO:0008144 |
drug binding
|
ACHE, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, HSP90AA1, HSP90AB1, NQO2, PIK3CA, PIK3CB, PPARA, PPARG |
3.2368 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.10062 |
[MF] GO:0004930 |
None
|
ADORA1, ADORA3, CHRM1, CHRM2, CHRM3, CHRM5, GRM1, GRM3, GRM5, GRM8, HCAR2, PPARG |
3.08148 |
[MF] GO:0004666 |
prostaglandin-endoperoxide synthase activity
|
PTGS1, PTGS2 |
2.85273 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.85273 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.85273 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, PPARA, PPARG |
2.73136 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, PPARA, PPARG |
2.73136 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, CYP19A1, CYP1A2, NQO2, XDH |
2.67358 |
[MF] GO:0008227 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.51664 |
[MF] GO:0004970 |
None
|
GRIA2, GRIA4, GRIK5 |
2.51664 |
[MF] GO:0005234 |
None
|
GRIA2, GRIA4, GRIK5 |
2.51664 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, PPARA, PPARG |
2.46896 |
[MF] GO:0099583 |
None
|
GRM1, GRM5 |
2.46221 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.2259 |
[MF] GO:0004971 |
None
|
GRIA2, GRIA4 |
2.2259 |
[MF] GO:0005504 |
None
|
FABP3, FABP4, PPARG |
2.14651 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.14651 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.04434 |